COVID-19 vaccines: Knowing the unknown.
Eur J Immunol
; 50(7): 939-943, 2020 07.
Article
em En
| MEDLINE
| ID: mdl-32437587
ABSTRACT
Vaccine development against SARS-CoV-2 has drawn attention around the globe due to the exploding pandemic. Although COVID-19 is caused by a new coronavirus, SARS-CoV-2, previous research on other coronavirus vaccines, such as FIPV, SARS, and MERS, has provided valuable information for the rapid development of COVID-19 vaccine. However, important knowledge gaps remain - some are specific to SARS-CoV-2, others are fundamental to immunology and vaccinology. Here, we discuss areas that need to be addressed for COVID-19 vaccine development, and what can be learned from examples of vaccine development in the past. Since the beginning of the outbreak, the research progress on COVID-19 has been remarkable. We are therefore optimistic about the rapid development of COVID-19 vaccine.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia Viral
/
Vacinas Virais
/
Infecções por Coronavirus
/
Pandemias
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article